Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 202
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07359105 | Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) | ||
| NCT01830517 | Diurnal Variation in Hypertensive Stroke Patients | ||
| NCT01822340 | Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients | ||
| NCT01505777 | Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT05407220 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers. | ||
| NCT04081844 | A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects. | ||
| NCT01894399 | Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT07219589 | A SAD Study of HM17321 in Healthy Adult Participants | ||
| NCT02057887 | Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A) | ||
| NCT01913847 | Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension | ||
| NCT05450575 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet | ||
| NCT02529800 | Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers | ||
| NCT05155995 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT03110874 | Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control | ||
| NCT01638286 | Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects | ||
| NCT06357910 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT06724016 | Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors | ||
| NCT04252963 | Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) | ||
| NCT01651481 | Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination | ||
| NCT01447797 | A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin | ||
| NCT02387554 | Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 | ||
| NCT05450601 | A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients | ||
| NCT02390882 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH | ||
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | ||
| NCT04654702 | Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap. | ||
| NCT04252872 | Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers | ||
| NCT04764201 | The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers | ||
| NCT04967014 | Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers | ||
| NCT04732416 | HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) | ||
| NCT05199129 | Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients | ||
| NCT01455571 | Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors | ||
| NCT01864863 | To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers | ||
| NCT02473900 | Evaluating the Bioequivalence of HIP1403, HGP0919 | ||
| NCT02127320 | Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe | ||
| NCT06234397 | Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors | ||
| NCT04652349 | Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia | ||
| NCT03372850 | Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT01030315 | A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects | ||
| NCT04084197 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects. | ||
| NCT02941848 | Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers | ||
| NCT00998283 | Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean Subjects | ||
| NCT03330327 | Molar Potency Study of HM12470 in Healthy Subjects | ||
| NCT04830449 | Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients | ||
| NCT02523547 | Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude | ||
| NCT04084184 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects | ||
| NCT03744182 | A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD | ||
| NCT03228277 | Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA |
